Visits: 1355, Avg visit time (secs): 166,35 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 462 | 34,10% | |
| /recipients.html | 380 | 28,04% |
| /amylin/efsd-amylin-recipients.html | 56 | 4,13% |
| /lifescan/efsd-lifescan-recipients.html | 54 | 3,99% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 36 | 2,66% |
| /lilly/efsd-lilly-recipients.html | 36 | 2,66% |
| /cr grant/efsd-clinres-recipients.html | 21 | 1,55% |
| /gsk/efsd-gsk-recipients.html | 15 | 1,11% |
| /dcure/efsd-dcure-recipients.html | 14 | 1,03% |
| /lilly/programme/efsd-lilly-rfa08.html | 13 | 0,96% |
| /novo-t1/efsd-novo-t1-recipients.html | 11 | 0,81% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 598 | 44,13% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 89 | 6,57% |
| /lilly/efsd-lilly-recipients.html | 77 | 5,68% |
| /dcure/efsd-dcure-recipients.html | 52 | 3,84% |
| /programmes.html | 51 | 3,76% |
| /reports.html | 30 | 2,21% |
| /lilly/efsd-lilly-mh-recipients.html | 28 | 2,07% |
| /gsk/efsd-gsk-recipients.html | 25 | 1,85% |
| /bms/efsd-bms-recipients.html | 24 | 1,77% |
| /home.html | 23 | 1,70% |
| /reviewers.html | 19 | 1,40% |